ATE259663T1 - Positronenemissions-tomographie mit benutzung von gallium-68 chelaten - Google Patents
Positronenemissions-tomographie mit benutzung von gallium-68 chelatenInfo
- Publication number
- ATE259663T1 ATE259663T1 AT99921656T AT99921656T ATE259663T1 AT E259663 T1 ATE259663 T1 AT E259663T1 AT 99921656 T AT99921656 T AT 99921656T AT 99921656 T AT99921656 T AT 99921656T AT E259663 T1 ATE259663 T1 AT E259663T1
- Authority
- AT
- Austria
- Prior art keywords
- dtpa
- lys
- complex
- target site
- chelate
- Prior art date
Links
- GYHNNYVSQQEPJS-YPZZEJLDSA-N Gallium-68 Chemical compound [68Ga] GYHNNYVSQQEPJS-YPZZEJLDSA-N 0.000 title 1
- 238000002600 positron emission tomography Methods 0.000 title 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 abstract 4
- 230000027455 binding Effects 0.000 abstract 3
- AVXRNUMVGRLMBL-GJZGRUSLSA-N (2s)-2-[[(2s)-2-acetamido-3-phenylpropanoyl]amino]-6-aminohexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)C)CC1=CC=CC=C1 AVXRNUMVGRLMBL-GJZGRUSLSA-N 0.000 abstract 2
- 108010030011 N-acetylphenylalanyllysine Proteins 0.000 abstract 2
- 238000012879 PET imaging Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000008685 targeting Effects 0.000 abstract 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 abstract 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6893—Pre-targeting systems involving an antibody for targeting specific cells clearing therapy or enhanced clearance, i.e. using an antibody clearing agents in addition to T-A and D-M
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8454898P | 1998-05-07 | 1998-05-07 | |
| PCT/US1999/009759 WO1999056792A1 (en) | 1998-05-07 | 1999-05-06 | Positron emission tomography using gallium-68 chelates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE259663T1 true ATE259663T1 (de) | 2004-03-15 |
Family
ID=22185670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99921656T ATE259663T1 (de) | 1998-05-07 | 1999-05-06 | Positronenemissions-tomographie mit benutzung von gallium-68 chelaten |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1075287B1 (de) |
| JP (1) | JP2002513776A (de) |
| AT (1) | ATE259663T1 (de) |
| AU (1) | AU740563B2 (de) |
| CA (1) | CA2331348C (de) |
| DE (1) | DE69914892T2 (de) |
| ES (1) | ES2216510T3 (de) |
| WO (1) | WO1999056792A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6962702B2 (en) * | 1998-06-22 | 2005-11-08 | Immunomedics Inc. | Production and use of novel peptide-based agents for use with bi-specific antibodies |
| US7067111B1 (en) | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| DK1286704T3 (da) | 2000-06-02 | 2014-09-22 | Univ Texas | Ethylendicystein (EC)-glucose analoge konjugater |
| US7011816B2 (en) * | 2001-12-26 | 2006-03-14 | Immunomedics, Inc. | Labeling targeting agents with gallium-68 and gallium-67 |
| US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
| US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1260827A (en) * | 1984-08-31 | 1989-09-26 | Richard C. Siegel | Antibody-metal ion complexes |
| FR2652004B1 (fr) * | 1989-09-21 | 1994-10-28 | Immunotech Partners | Nouveaux derives hydrophiles, application au diagnostic et a la therapeutique, kits diagnostiques ou therapeutiques et reactifs immunologiques. |
| ZA938243B (en) * | 1992-11-12 | 1995-05-04 | Hybritech Inc | Altered affinity polypeptides of metal chelate binding antibodies |
| US5686578A (en) * | 1994-08-05 | 1997-11-11 | Immunomedics, Inc. | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
-
1999
- 1999-05-06 AT AT99921656T patent/ATE259663T1/de not_active IP Right Cessation
- 1999-05-06 AU AU38806/99A patent/AU740563B2/en not_active Ceased
- 1999-05-06 DE DE69914892T patent/DE69914892T2/de not_active Expired - Lifetime
- 1999-05-06 ES ES99921656T patent/ES2216510T3/es not_active Expired - Lifetime
- 1999-05-06 WO PCT/US1999/009759 patent/WO1999056792A1/en not_active Ceased
- 1999-05-06 CA CA002331348A patent/CA2331348C/en not_active Expired - Fee Related
- 1999-05-06 EP EP99921656A patent/EP1075287B1/de not_active Expired - Lifetime
- 1999-05-06 JP JP2000546816A patent/JP2002513776A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2331348A1 (en) | 1999-11-11 |
| AU3880699A (en) | 1999-11-23 |
| CA2331348C (en) | 2007-07-24 |
| WO1999056792A1 (en) | 1999-11-11 |
| DE69914892T2 (de) | 2004-12-30 |
| DE69914892D1 (de) | 2004-03-25 |
| EP1075287B1 (de) | 2004-02-18 |
| AU740563B2 (en) | 2001-11-08 |
| ES2216510T3 (es) | 2004-10-16 |
| EP1075287A1 (de) | 2001-02-14 |
| JP2002513776A (ja) | 2002-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Akizawa et al. | Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins | |
| Chang et al. | Molecular advances in pretargeting radioimunotherapy with bispecific antibodies | |
| Grünberg et al. | Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model | |
| Wängler et al. | Antibody− dendrimer conjugates: The number, not the size of the dendrimers, determines the immunoreactivity | |
| RU2539915C2 (ru) | Набор для предварительного придания направленности действия, способ и средства, применяемые в нем | |
| Wilbur et al. | Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab ‘colocalization with recombinant streptavidin and avidin | |
| Sharkey et al. | Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy | |
| Vugts et al. | Synthesis of phosphine and antibody–azide probes for in vivo Staudinger ligation in a pretargeted imaging and therapy approach | |
| JPS635033A (ja) | 化合物標的化組成物 | |
| Rondon et al. | Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept | |
| CA2335364A1 (en) | Use of bi-specific antibodies for pre-targeting diagnosis and therapy | |
| JP2014500307A5 (de) | ||
| RU2004122695A (ru) | Мечение галлием-68 и галлием-67 средств для направленной доставки | |
| US20110117012A1 (en) | Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr expression in malignant tumors | |
| Rogers et al. | Targeted radiotherapy with [90Y]‐SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector | |
| Jo et al. | Cancer therapy by antibody-targeted Cerenkov light and metabolism-selective photosensitization | |
| DE69914892D1 (de) | Positronenemissions-tomographie mit benutzung von gallium-68 chelaten | |
| Meredith et al. | Pretargeted radioimmunotherapy | |
| Arano | Strategies to reduce renal radioactivity levels of antibody fragments | |
| Vriesendorp et al. | Review of five consecutive studies of radiolabeled immunoglobulin therapy in Hodgkin's disease | |
| Tatsumi et al. | In vivo-stable bis-iminobiotin for targeted radionuclide delivery with the mutant streptavidin | |
| Li et al. | Avidin-biotin system pretargeting radioimmunoimaging and radioimmunotherapy and its application in mouse model of human colon carcinoma | |
| Sundberg et al. | Cellular retention of radioactivity and increased radiation dose. Model experiments with EGF-dextran | |
| Ferro-Flores et al. | Preparation, biodistribution, and dosimetry of 188Re-Labeled MoAb ior cea1 and its f (ab′) 2 fragments by avidin-biotin strategy | |
| Hauck et al. | Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection relative to hyperthermia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1075287 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |